VEA
SANA icon

Virtus ETF Advisers’s Sana Biotechnology SANA Stock Holding History

Virtus ETF Advisers’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34,849
Closed -$56.8K – 733
2024
Q4 		$56.8K Buy
34,849
+21,959
+170% +$65.5K 0.02% 455
2024
Q3 		$53.6K Buy
12,890
+229
+2% +$1.2K 0.03% 440
2024
Q2 		$69.1K Sell
12,661
-9,053
-42% -$72.1K 0.03% 434
2024
Q1 		$217K Sell
21,714
-1,489
-6% -$11.2K 0.12% 239
2023
Q4 		$94.7K Buy
+23,203
New +$85.5K 0.06% 385

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtus ETF Advisers's SANA Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Sana Biotechnology (SANA) in Q1 2025, closing a stake of 34,849 shares — an estimated $56.8K sold.

Virtus ETF Advisers first reported a position in SANA in Q4 2023 and held it in 5 quarters. The position peaked at $217K in Q1 2024. 161 funds tracked by Wall St. Rank hold SANA as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Sana Biotechnology position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 34,849 Sana Biotechnology shares in Q1 2025, an estimated $56.8K.
  • Virtus ETF Advisers first reported a position in Sana Biotechnology in Q4 2023 and held it in 5 quarters.
  • Virtus ETF Advisers's Sana Biotechnology position peaked at $217K in Q1 2024.
  • 161 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.